Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,410 | 75 | 99.3% |
| Education | $10.52 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $385.44 | 18 | $0 (2024) |
| PFIZER INC. | $254.71 | 12 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $138.82 | 9 | $0 (2024) |
| Novo Nordisk Inc | $122.25 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $86.39 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $76.27 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $66.28 | 3 | $0 (2024) |
| Bausch Health US, LLC | $62.19 | 4 | $0 (2024) |
| Allergan Inc. | $37.61 | 3 | $0 (2018) |
| PBG PUERTO RICO LLC | $28.37 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $465.22 | 23 | ABBVIE INC. ($96.13) |
| 2023 | $183.56 | 9 | ABBVIE INC. ($123.57) |
| 2022 | $163.73 | 8 | ABBVIE INC. ($87.71) |
| 2021 | $159.03 | 7 | AbbVie Inc. ($57.63) |
| 2020 | $19.39 | 1 | Ultragenyx Pharmaceutical Inc. ($19.39) |
| 2019 | $145.94 | 9 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($39.11) |
| 2018 | $172.38 | 11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($48.85) |
| 2017 | $110.84 | 8 | AstraZeneca Pharmaceuticals LP ($40.18) |
All Payment Transactions
76 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Biological | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: PAIN | ||||||
| 10/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: PAIN | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Respiratory | ||||||
| 10/04/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Neurology | ||||||
| 09/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Biological | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Gastroenterology | ||||||
| 09/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: VACCINES | ||||||
| 06/18/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Neurology | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Gastroenterology | ||||||
| 05/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Biological | ||||||
| 03/20/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Neurology | ||||||
| 01/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
| 01/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Gastroenterology | ||||||
| 12/06/2023 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Neurology | ||||||
| 11/08/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 382 | 487 | $48,799 | $33,854 |
| 2022 | 9 | 391 | 497 | $39,926 | $26,581 |
| 2021 | 9 | 448 | 583 | $42,975 | $30,290 |
| 2020 | 10 | 454 | 563 | $41,834 | $25,645 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 119 | $19,040 | $12,040 | 63.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 66 | 66 | $11,428 | $9,710 | 85.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 65 | $7,150 | $4,564 | 63.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 32 | 32 | $2,880 | $2,298 | 79.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $2,810 | $2,061 | 73.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 32 | 32 | $1,172 | $1,098 | 93.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 14 | 16 | $1,280 | $902.12 | 70.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 69 | 87 | $1,740 | $730.80 | 42.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 34 | 37 | $1,036 | $401.10 | 38.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 21 | 22 | $264.00 | $48.40 | 18.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 67 | 67 | $11,601 | $10,208 | 88.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 98 | $15,680 | $9,500 | 60.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 35 | $3,850 | $2,586 | 67.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 32 | 32 | $2,880 | $2,193 | 76.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 33 | 33 | $825.00 | $808.50 | 98.0% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 13 | 14 | $1,050 | $499.69 | 47.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 87 | 138 | $2,760 | $408.39 | 14.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 18 | 20 | $560.00 | $244.72 | 43.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 54 | 60 | $720.00 | $133.03 | 18.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 99 | $15,840 | $10,618 | 67.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 68 | 68 | $11,774 | $10,598 | 90.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 53 | 53 | $4,240 | $3,455 | 81.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 37 | $4,069 | $3,087 | 75.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 53 | 53 | $1,325 | $1,063 | 80.2% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 11 | 12 | $900.00 | $506.44 | 56.3% |
About Dr. Kaleen Kitay, M.D
Dr. Kaleen Kitay, M.D is a Internal Medicine healthcare provider based in Mc Lean, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114025376.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kaleen Kitay, M.D has received a total of $1,420 in payments from pharmaceutical and medical device companies, with $465.22 received in 2024. These payments were reported across 76 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,410).
As a Medicare-enrolled provider, Kitay has provided services to 1,675 Medicare beneficiaries, totaling 2,130 services with total Medicare billing of $116,371. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Mc Lean, VA
- Active Since 09/20/2006
- Last Updated 07/25/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114025376
Products in Payments
- QULIPTA (Drug) $245.13
- UBRELVY (Drug) $119.91
- PREVNAR 20 (Biological) $95.46
- XIFAXAN (Drug) $89.97
- NURTEC ODT (Drug) $74.07
- Veozah (Drug) $66.28
- APLENZIN (Drug) $62.19
- PREVNAR - 13 (Biological) $61.94
- PREVNAR 13 (Biological) $58.69
- Rybelsus (Drug) $55.55
- XIFAXANIBSD (Drug) $48.85
- Ozempic (Drug) $45.88
- SYMBICORT (Drug) $39.63
- SHINGRIX (Biological) $30.04
- Trintellix (Drug) $23.88
- ADVAIR (Drug) $23.74
- MOUNJARO (Drug) $23.42
- BREZTRI (Drug) $22.11
- Tresiba (Drug) $20.82
- Synthroid (Drug) $20.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mc Lean
Dr. Gautam Gulati, M.d, M.D
Internal Medicine — Payments: $135,800
Dr. Courtney Blair, M.d, M.D
Internal Medicine — Payments: $106,709
Dr. Mohammed Al-Dalli, M.d, M.D
Internal Medicine — Payments: $12,620
Dr. Shore Armani, M.d, M.D
Internal Medicine — Payments: $5,553
Kawan Barawy, Md, MD
Internal Medicine — Payments: $1,118
Dr. Mandana Shafai, M.d, M.D
Internal Medicine — Payments: $810.10